Evidence map›Paper›PMID 41345432›Full record

ArticleScientific reports2025

ReHA-Net: a ReVIN-hybrid attention network with multiscale convolution for robust EEG artifact removal in brain-computer interfaces.

Neenu Francis, G Vadivu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Neenu FrancisDepartment of Data Science and Business Systems, School of Computing, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India. nf5767@srmist.edu.in.
G VadivuDepartment of Data Science and Business Systems, School of Computing, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electroencephalography (EEG) is a non-invasive technique for monitoring brain activity, but its signal quality is frequently degraded by artifacts from ocular movements, muscle activity, and environmental noise. ReHA-Net is a deep learning framework for robust EEG denoising, combining a U-Net-based encoder-decoder with three core modules. (1) Hybrid Attention integrates temporal, spatial, and frequency attention to emphasize neural patterns while suppressing structured noise. (2) The Multiscale Separable Convolution (MSC) block employs dilated and parallel depth-wise separable convolutions with varying kernel sizes to capture both short-term and long-term temporal dependencies. (3) Reversible Instance Normalization (ReVIN) enhances cross-subject generalization while retaining subject-specific features. The model trains on an enhanced EEGdenoiseNet dataset with a wider signal-to-noise ratio range, combined artifact conditions, and tailored normalization strategies. ReHA-Net achieved strong denoising performance, with a PSNR of 27.10 dB, an SNR of about 17.06 dB, and a correlation coefficient of 0.976 with clean signals and a relative root mean square error (RRMSE) of 0.165. These outcomes demonstrate effective artifact reduction while maintaining neural activity, highlighting its suitability as a preprocessing step for tasks such as seizure detection, imagined speech decoding, and cognitive state monitoring.

Indexed as

ArtifactsBrainBrain-Computer InterfacesElectroencephalographyAlgorithmsDeep LearningHumansSignal Processing, Computer-AssistedSignal-To-Noise RatioArtifact suppressionAttention mechanismsBiomedical signal processingComputational intelligenceDeep learningElectroencephalography denoisingReversible instance normalization

Identifiers

PMID41345432
PMCPMC12764841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.